sgntuc-019: tucatinib trastuzumab for previously treated her2 metastatic biliary tract cancer
Published 1 year ago • 155 plays • Length 2:21Download video MP4
Download video MP3
Similar videos
-
0:52
the significance of tucatinib trastuzumab as a chemotherapy-free option for her2 metastatic btc
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
2:23
mountaineer-02: tucatinib in previously treated her2 gastric cancer
-
1:24
tucatinib and trastuzumab in the treatment paradigm of her2-positive mcrc
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
3:15
her2climb-02: tucatinib tdm-1 in advanced breast cancer
-
1:14
updated analysis from mountaineer: tucatinib and trastuzumab for her2-positive mcrc
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
0:56
mountaineer results: trastuzumab and tucatinib for her2 mcrc
-
1:39
treatment for her2 metastatic breast cancer
-
1:11
32 month follow-up of mountaineer: tucatinib and trastuzumab in her2 mcrc
-
2:15
treatment strategies for her2 metastatic breast cancer
-
2:10
treating cns metastases in her2 breast cancer
-
1:56
treating her2 breast cancer with brain metastases
-
2:01
her2climb: tucatinib in combination w/ capecitabine & trastuzumab
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer